For US Healthcare Professionals
- Efficacy in PsO
- Safety Profile
- Mechanism of Action
- Support and Resources
- Efficacy in PsA
|Baseline BSA involvement||54%|
|Psoriasis duration||12 years|
|Previous therapies||topicals, biologics|
|Age||BMI||Baseline BSA involvement||Psoriasis duration||Previous therapies|
|36||31.1 kg/m2||54%||12 years||topicals, biologics|
*Individual results may vary. Plaque psoriasis photos are of a real patient from VOYAGE 2 who received TREMFYA® 100 mg at Weeks 0 and 4, and q8w thereafter through Week 48. Other areas affected (not shown) yielded similar results to those depicted here. Images are for illustrative purposes only and are used with permission from Janssen Biotech, Inc.
Reference: 1. Data on file. Janssen Biotech, Inc.